← Leaderboards
Ricardo Cruciani
Weill Medical College Of Cornell Univ
$865,343
Attributed
$865,343
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$865,343 · 3
By mechanism
R21$785,818 · 2
M01$79,525 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- Selina Y Chen-Kiang$10,455,922
- Bruce R Schackman$21,876,043
- Ruben Niesvizky$630,956
- Patricia J Giardina$4,084,595
- Norman R. Relkin$3,431,964
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectCarnitineDietary SupplementsNutrition Related TagHuman Therapy EvaluationFatiguePatient Oriented ResearchQuality Of LifeClinical ResearchAidsAids Dementia ComplexAids TherapyAlternative MedicineBioenergeticsBlood ChemistryDietary AminoacidDiet TherapyEmotionsMedical ComplicationNeoplasm /Cancer Palliative TreatmentOutcomes ResearchPerformancePsychomotor FunctionTerminal Patient Care
Grant awards (5)
Phase II Developmental Study on Fatigue in AIDS Patients$212,947
R21 · FY2003 · NR
Phase II Developmental Study on Fatigue in AIDS Patients$211,147
R21 · FY2002 · NR
Phase II Developmental Study on Fatigue in Cancer$180,862
R21 · FY2002 · AT
Phase II Developmental Study on Fatigue in Cancer$180,862
R21 · FY2001 · AT
ULTRA LOW DOSE NALTREXONE &HEROIN WITHDRAWAL: PILOT STUDY$79,525
M01 · FY2000 · RR